Voice your opinion on congressional bill S3129-116 and let lawmakers know your stance with UnPac!

Main Subject: Health

Lower Costs, More Cures Act of 2019

This bill establishes and modifies several requirements to address prescription drug prices under Medicare.

The bill generally

limits payment amounts for drugs and biologics under Medicare medical services,
reduces cost-sharing under the Medicare prescription drug benefit, and
establishes several reporting requirements for drug manufacturers with respect to drug prices.

HR1264-116, HR1781-116, HR1922-116, HR2073-116, HR2087-116, HR2115-116, HR2209-116, HR3029-116, HR3408-116, HR3415-116, HR4649-116, S801-116, S1505-116, S1999-116, S2051-116, S2911-116, S3013-116, S3942-116, HR7877-116, HR19-116,

Categories

Administrative law and regulatory procedures Advisory bodies Business records Civil actions and liability Competitiveness, trade promotion, trade deficits Congressional oversight Consumer affairs Executive agency funding and structure Federal officials Fraud offenses and financial crimes Government employee pay, benefits, personnel management Government information and archives Health care costs and insurance Health care coverage and access Health information and medical records Health personnel Health programs administration and funding Health technology, devices, supplies Income tax deductions Competitiveness trade promotion trade deficits Government employee pay benefits personnel management Health technology devices supplies Health

Senate Actions

IntroReferral
Dec. 19 2019	Read twice and referred to the Committee on Finance.

Library of Congress Actions

IntroReferral
Dec. 19 2019	Introduced in Senate

Senate bill S3129-116

Lower Costs, More Cures Act of 2019

Promote the cause!

Or use this QR code